Selenium deficiency in total parenteral nutrition.

1. Forms of Selenium.- 1.1 Low Molecular-Weight Compounds.- 1.1.1 Selenocysteine.- 1.1.2 Selenocystine.- 1.1.3 Selenohomocystine.- 1.1.4 Se-methylselenocysteine.- 1.1.5 Selenocystathionine.- 1.1.6 Selenomethionine.- 1.1.7 Se-methylselenomethionine.- 1.1.8 Dimethyl Selenide.- 1.1.9 Dimethyl Diselenide.- 1.1.10 Trimethyl Selenonium.- 1.1.11 Elemental Selenium.- 1.1.12 Selenotaurine.- 1.1.13 Selenocoenzyme A.- 1.1.14 Other Compounds.- 1.2 Macromolecular Forms of Selenium.- 1.2.1 Formate Dehydrogenase.- 1.2.2 Glycine Reductase.- 1.2.3 Nicotinic Acid Hydroxylase.- 1.2.4 Xanthine Hydrogenase.- 1.2.5 Thiolase.- 1.2.6 Glutathione Peroxidase.- 1.2.7 Miscellaneous Selenoproteins.- 1.2.8 Seleno-tRNA's.- 11.11 References.- 2. Selenium Deficiency Diseases in Animals.- 2.1 Introduction.- 2.2 Dietary Liver Necrosis and Factor 3.- 2.2.1 Discovery.- 2.2.2 Pathology.- 2.2.3 Biochemical Defect.- 2.2.4 Hepatosis Dietetica.- 2.3 Nutritional Muscular Dystrophy.- 2.3.1 Pathology.- 2.3.2 Prevention of NMD.- 2.4 Exudative Diathesis.- 2.5 Pancreatic Degeneration.- 2.6 Mulberry Heart Disease.- 2.7 Reproductive Problems.- 2.8 Myopathy of the Gizzard.- 2.9 Growth.- 2.10 Selenium-Responsive Unthriftiness of Sheep and Cattle.- 2.11 Periodontal Disease of Ewes.- 2.12 Encephalomalacia.- 11.11 References.- 3. Metabolism of Selenium.- 3.1 Absorption.- 3.2 Placental Transfer.- 3.3 Mechanism of the Antioxidant Action of Selenium.- 3.4 Effect of Paraquat.- 3.5 Effect on Cytochrome P-450.- 3.6 Selenium and Hepatic Heme Metabolism.- 11.11 References.- 4. Comparative Metabolism and Biochemistry of Selenium and Sulphur.- 4.1 Introduction.- 4.2 Comparative Metabolism of Selenium and Sulphur.- 4.2.1 Microorganisms.- 4.2.2 Plants.- 4.2.3 Animals.- 4.3 Comparative Biochemistry of Selenium and Sulphur.- 4.3.1 Selenopersulfide as an Electron Transfer Catalyst.- 4.3.2 Iron-Sulphur Proteins.- 4.3.3 Sulphur Salts and Selenium Toxicity in Animals.- 4.3.4 Other Selenium-Sulphur Interactions.- 11.11 References.- 5. Biological Interactions of Selenium with Other Substances.- 5.1 Cadmium.- 5.1.1 Pathological Effects.- 5.1.2 Cadmium-Zinc Interactions.- 5.1.3 Cadmium-Selenium Interactions.- 5.1.4 Effect on Drug Response.- 5.2 Arsenic.- 5.3 Copper.- 5.4 Silver.- 5.5 Cobalt.- 5.6 Manganese.- 5.7 Lead.- 5.8 Mercury.- 5.8.1 Inorganic and Organic Mercury.- 5.8.2 Tissue Distribution.- 5.8.3 Properties of the Mercury-Selenium Complex.- 5.8.4 Teratogenicity.- 5.9 Thallium.- 5.10 Tellurium.- 5.11 Vanadium.- 5.12 Bismuth.- 5.13 Other Substances.- 11.11 References.- 6. Environmental Occurrence of Selenium.- 6.1 Geochemistry of Selenium.- 6.2 Soil Selenium.- 6.3 Uptake and Concentration of Trace Elements in the Roots, Stems, and Leaves of Plants.- 6.4 Forage Selenium.- 6.5 Selenium in Water.- 6.6 Selenium in Food.- 6.7 Intakes and Recommended Daily Allowance in Humans.- 6.8 Regulations in Regard to Animal Diets.- 11.11 References.- 7. Toxicity of Selenium.- 7.1 Introduction.- 7.1.1 Acute Toxicity.- 7.1.2 Blind Staggers.- 7.1.3 Alkalai Disease.- 7.1.4 Toxicity in Rabbits.- 7.1.5 Toxicity in Hamsters.- 7.1.6 Toxicity in Sheep.- 7.1.7 Toxicity in Rats.- 7.1.8 Effect of Diet on Toxicity.- 7.1.9 Biochemical Lesions.- 7.1.10 LD50 of Various Selenium Compounds.- 7.2 Industrial Medical Aspects.- 7.2.1 Occupational Hazards.- 7.2.2 Permissible Limits for Selenium Exposure.- 7.2.3 Toxicity in Humans.- 11.11 References.- 8. Selenium in Health and Disease.- 8.1 Selenium and Cancer.- 8.1.1 Skin Cancer.- 8.1.2 Liver Cancer.- 8.1.3 Colon Cancer.- 8.1.4 Breast Cancer.- 8.1.5 Tracheal Cancer.- 8.1.6 Chemotherapeutic Effect of Selenium.- 8.1.7 Epidemiological Relationship.- 8.1.8 Selenium Blood Levels in Cancer Patients.- 8.1.9 Selenium as a Carcinogen.- 8.2 Selenium and Mutagenesis.- 8.2.1 Antimutagenicity.- 8.2.2 Mutagenicity.- 8.3 Selenium and Immunity.- 8.3.1 Effect of Selenium on Humoral Immunity.- 8.3.2 Cell-Mediated Immunity.- 8.3.3 Nonspecific Immune Effects of Selenium.- 8.4 Selenium and Dental Caries.- 8.5 The Anti-Inflammatory Properties of Selenium.- 8.6 Selenium and Heart Disease.- 8.6.1 Animals.- 8.6.2 Humans.- 8.7 Selenium and Aging.- 8.8 Cystic Fibrosis.- 8.9 Multiple Sclerosis.- 8.10 Cataracts.- 8.11 Other Diseases.- 8.12 Radioselenium as a Diagnostic Agent.- 11.11 References.- 9. Synthetic Forms of Selenium and Their Chemotherapeutic Uses.- 9.1 Anti-Infective Agents.- 9.1.1 Antibacterial.- 9.1.2 Antiviral.- 9.2 Antifungal Agents.- 9.3 Antiparasitic Agents.- 9.4 Compounds Affecting the Central Nervous System.- 9.4.1 Hypnotics.- 9.4.2 Analgesics and Local Anesthetics.- 9.4.3 Tranquilizing Drugs.- 9.5 Compounds that Affect the Autonomic Nervous System.- 9.6 Compounds that Affect the Circulatory System.- 9.7 Anti-Inflammatory Compounds.- 9.8 Antihistamines.- 9.9 Anticancer Agents.- 9.10 Antiradiation Agents.- 9.11 Steroids.- 9.12 Selenocoenzyme A.- 9.13 Selenium-Containing Carbohydrates.- 9.14 Seleno-Amino Acids.- 11.11 References.- 10. Analytical Methods of Selenium Determination.- 10.1 Introduction.- 10.2 Sample Preparation and Storage.- 10.3 Destructive Analysis.- 10.3.1 Ashing.- 10.3.2 Closed-System Combustion.- 10.3.3 Wet Digestion.- 10.3.4 Measurement of Selenium.- 10.4 Nondestructive Analysis.- 10.4.1 Neutron Activation Analysis.- 10.4.2 X-Ray Fluorescence Analysis.- 10.4.3 Proton-Induced X-Ray Emission.- References.

/pdf/biochemistry-of-selenium-gu73q1uo0t.pdf

Biochemistry of selenium.

Nutrient requirements of all livestock are based on the size of the animal, how active the animal is, the body growth rate, and/or the animal’s level of milk production and fat content in milk produced. Maintenance requirements are for low levels of activity as when being fed in a dry lot situation. When animals are on pasture activity increases and these the requirements may be as much as 25% higher due to this increased activity.

Nutrient Requirements of Sheep

DISCLAIMER The use of company or product name(s) is for identification only and does not imply endorsement by the Agency for Toxic Substances and Disease Registry. A Toxicological Profile for cobalt, Draft for Public Comment was released in July 2001. This edition supersedes any previously released draft or final profile. Toxicological profiles are revised and republished as necessary. For information regarding the update status of previously released profiles, contact ATSDR at: vi Background Information The toxicological profiles are developed by ATSDR pursuant to Section 104(i) (3) and (5) of the Comprehensive Environmental Response, Compensation, and Liability Act of 1980 (CERCLA or Superfund) for hazardous substances found at Department of Energy (DOE) waste sites. CERCLA directs ATSDR to prepare toxicological profiles for hazardous substances most commonly found at facilities on the CERCLA National Priorities List (NPL) and that pose the most significant potential threat to human health, as determined by ATSDR and the EPA. ATSDR and DOE entered into a Memorandum of Understanding on November 4, 1992 which provided that ATSDR would prepare toxicological profiles for hazardous substances based upon ATSDR=s or DOE=s identification of need. The current ATSDR priority list of hazardous substances at DOE NPL sites was announced in the Toxicological Profiles are a unique compilation of toxicological information on a given hazardous substance. Each profile reflects a comprehensive and extensive evaluation, summary, and interpretation of available toxicologic and epidemiologic information on a substance. Health care providers treating patients potentially exposed to hazardous substances will find the following information helpful for fast answers to often-asked questions. Chapter 1: Public Health Statement: The Public Health Statement can be a useful tool for educating patients about possible exposure to a hazardous substance. It explains a substance's relevant toxicologic properties in a nontechnical, question-and-answer format, and it includes a review of the general health effects observed following exposure. Chapter 3: Health Effects: Specific health effects of a given hazardous compound are reported by type of health effect (death, systemic, immunologic, reproductive), by route of exposure, and by length of exposure (acute, intermediate, and chronic). In addition, both human and animal studies are reported in this section. NOTE: Not all health effects reported in this section are necessarily observed in the clinical setting. Please refer to the Public Health Statement to identify general health effects observed following exposure. The following additional material can be ordered through the ATSDR Information Center: Case Studies in …

/pdf/toxicological-profile-for-cobalt-tjzamtgcf3.pdf

Toxicological profile for cobalt

A study of the chemical element selenium, which plays an integral yet poorly understood role in the function of living cells. The text covers discoveries in human and animal nutrition, the structure of selenoproteins and research into selenium's physiological attributes.

Selenium in biology and human health.

The effects of selenium and vitamin E on blood selenium levels and tissue glutathione peroxidase activities were determined in sheep fed purified and hay diets. A significant increase of blood levels of this element and tissue glutathione peroxidase activities was found in sheep given selenium as compared to those not receiving this element. Of the tissues examined, the highest glutathione peroxidase activity was found in the heart. Vitamin E had no influence on either the blood selenium levels or upon the tissue glutathione peroxidase activity. With hydrogen peroxide as the substrate, tissue glutathione peroxidase activity was not correlated with the incidence of white muscle disease. Evidence is presented to suggest that 0.1 ppm dietary selenium is not sufficient under some conditions to meet the physiological requirements for this element.

Effects of selenium and vitamin E on blood selenium levels, tissue glutathione peroxidase activities and white muscle disease in sheep fed purified or hay diets.

Three 2 X 2 factorial experiments were conducted with sheep fed purified diets to determine the effects of selenium and vitamin E on the incidence of white muscle disease (WMD) and blood components. All lambs reaching 6 weeks of age in the group receiving no vitamin E or selenium developed WMD lesions, whereas only a few lambs in either the +E - Se or -E + Se treatment groups developed these lesions. Plasma activities of creatine phosphokinase, lactic dehydrogenase and glutamic oxaloacetic transaminase were significantly elevated in lambs receiving no vitamin E or selenium, whereas these enzyme activities in those receiving only selenium were non-significantly elevated. The enzyme activities in plasma of those on the +E - Se or +E + Se treatments were maintained at low levels, suggesting vitamin E alone is more effective in preventing WMD than selenium alone. The metabolic interactions of these essentials are discussed.

Effects of selenium and vitamin E deficiencies on reproduction, growth, blood components, and tissue lesions in sheep fed purified diets

Effects of Various Methods of Selenium Administration on White Muscle Disease, Glutathione Peroxidase and Plasma Enzyme Activities in Sheep

Effects of selenium, cadmium, mercury, tellurium, arsenic, silver and cobalt on white muscle disease in lambs and effect of dietary forms of arsenic on its accumulation in tissues

J. A. Schmitz

Papers

Effects of selenium and vitamin E on blood selenium levels, tissue glutathione peroxidase activities and white muscle disease in sheep fed purified or hay diets.

Effects of selenium and vitamin E deficiencies on reproduction, growth, blood components, and tissue lesions in sheep fed purified diets

Effects of Various Methods of Selenium Administration on White Muscle Disease, Glutathione Peroxidase and Plasma Enzyme Activities in Sheep

Effects of selenium, cadmium, mercury, tellurium, arsenic, silver and cobalt on white muscle disease in lambs and effect of dietary forms of arsenic on its accumulation in tissues